XML 77 R62.htm IDEA: XBRL DOCUMENT v3.19.1
Restructuring and Asset Impairment Charges - Summary of Activity Related to Restructuring Liability (Details)
$ in Millions
12 Months Ended
Mar. 31, 2019
USD ($)
Other  
Cost Alignment Plan  
Restructuring charges recognized $ 91
Strategic Growth Initiative Plan  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 331
Non-cash charges (33)
Cash payments (141)
Other (7)
Ending balance 150
Strategic Growth Initiative Plan | Operating Segments | U.S. Pharmaceutical and Specialty Solutions  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 63
Non-cash charges (6)
Cash payments (8)
Other (18)
Ending balance 31
Strategic Growth Initiative Plan | Operating Segments | European Pharmaceutical Solutions  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 41
Non-cash charges (5)
Cash payments (5)
Other 7
Ending balance 38
Strategic Growth Initiative Plan | Operating Segments | Medical-Surgical Solutions  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 42
Non-cash charges (3)
Cash payments (23)
Other (1)
Ending balance 15
Strategic Growth Initiative Plan | Operating Segments | Other  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 91
Non-cash charges (18)
Cash payments (52)
Other 8
Ending balance 29
Strategic Growth Initiative Plan | Corporate  
Cost Alignment Plan  
Beginning balance 0
Restructuring charges recognized 94
Non-cash charges (1)
Cash payments (53)
Other (3)
Ending balance 37
Other Accrued Liabilities | Strategic Growth Initiative Plan  
Cost Alignment Plan  
Ending balance 117
Other Noncurrent Liabilities | Strategic Growth Initiative Plan  
Cost Alignment Plan  
Ending balance $ 33